Communiqués iCAD, Inc.

Actions

ICAD

US44934S2068

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 15/07/2024			Varia. 5j.	Varia. 1 janv.
1,25 ^USD	-3,85 %		+1,63 %	-29,38 %

13/06	Transcript : ICAD, Inc. - Shareholder/Analyst Call
15/05	Transcript : ICAD, Inc., Q1 2024 Earnings Call, May 15, 2024

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

ICAD to Highlight Promising Research on Potential of its AI Algorithm to More Accurately Identify and Personalize Breast Cancer Risk at SIIM 2024	26/06	AQ
ICAD to Participate in the MedInvest MedTech, AI & Digital Health Conference	04/06	AQ
ICAD Reports Financial Results for First Quarter Ended March 31, 2024	15/05	AQ
ICAD to Report First Quarter 2024 Financial Results on May 15, 2024	02/05	AQ
ICAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium	11/04	AQ
ICAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation	09/04	AQ
ICAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting	08/04	AQ
ICAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)	03/04	AQ
ICAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale	02/04	AQ
ICAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists	19/03	AQ
ICAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results	12/03	AQ
ICAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings	28/02	AQ
ICAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)	27/02	AQ
ICAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024	27/02	AQ
ICAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference	06/02	AQ
ICAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member	30/01	AQ
ICAD Expands Executive Sales Leadership Team as Business Grows	18/12	AQ
ICAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare	28/11	AQ
ICAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease	27/11	AQ
ICAD and CancerIQ Announce Partnership to Integrate AI-Enabled Technology With Best-in-Class Risk Assessment and Care Management Platform Offering A Comprehensive Breast Health Care Solution	20/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués iCAD, Inc.

Actions

ICAD

US44934S2068

Communiqués

Filtres